CAH vs. BIIB
Compare and contrast key facts about Cardinal Health, Inc. (CAH) and Biogen Inc. (BIIB).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CAH or BIIB.
Correlation
The correlation between CAH and BIIB is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CAH vs. BIIB - Performance Comparison
Loading data...
Key characteristics
CAH:
2.69
BIIB:
-1.61
CAH:
3.48
BIIB:
-2.40
CAH:
1.48
BIIB:
0.73
CAH:
3.37
BIIB:
-0.59
CAH:
16.18
BIIB:
-1.44
CAH:
3.78%
BIIB:
30.91%
CAH:
22.19%
BIIB:
28.39%
CAH:
-61.58%
BIIB:
-90.00%
CAH:
0.00%
BIIB:
-73.61%
Fundamentals
CAH:
$36.27B
BIIB:
$18.13B
CAH:
$6.40
BIIB:
$10.12
CAH:
23.74
BIIB:
12.22
CAH:
0.78
BIIB:
6.24
CAH:
0.16
BIIB:
1.85
CAH:
16.07
BIIB:
1.04
CAH:
$222.29B
BIIB:
$9.70B
CAH:
$7.78B
BIIB:
$7.15B
CAH:
$2.81B
BIIB:
$2.15B
Returns By Period
In the year-to-date period, CAH achieves a 31.47% return, which is significantly higher than BIIB's -17.87% return. Over the past 10 years, CAH has outperformed BIIB with an annualized return of 8.99%, while BIIB has yielded a comparatively lower -10.85% annualized return.
CAH
31.47%
14.80%
30.90%
59.07%
29.48%
8.99%
BIIB
-17.87%
8.93%
-21.50%
-45.41%
-16.92%
-10.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CAH vs. BIIB — Risk-Adjusted Performance Rank
CAH
BIIB
CAH vs. BIIB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cardinal Health, Inc. (CAH) and Biogen Inc. (BIIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CAH vs. BIIB - Dividend Comparison
CAH's dividend yield for the trailing twelve months is around 1.31%, while BIIB has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CAH Cardinal Health, Inc. | 1.31% | 1.28% | 1.98% | 2.57% | 3.80% | 3.62% | 3.79% | 4.24% | 2.99% | 2.41% | 1.68% | 1.65% |
BIIB Biogen Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
CAH vs. BIIB - Drawdown Comparison
The maximum CAH drawdown since its inception was -61.58%, smaller than the maximum BIIB drawdown of -90.00%. Use the drawdown chart below to compare losses from any high point for CAH and BIIB. For additional features, visit the drawdowns tool.
Loading data...
Volatility
CAH vs. BIIB - Volatility Comparison
The current volatility for Cardinal Health, Inc. (CAH) is 7.45%, while Biogen Inc. (BIIB) has a volatility of 9.33%. This indicates that CAH experiences smaller price fluctuations and is considered to be less risky than BIIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CAH vs. BIIB - Financials Comparison
This section allows you to compare key financial metrics between Cardinal Health, Inc. and Biogen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CAH vs. BIIB - Profitability Comparison
CAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Cardinal Health, Inc. reported a gross profit of 2.12B and revenue of 54.88B. Therefore, the gross margin over that period was 3.9%.
BIIB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a gross profit of 1.80B and revenue of 2.43B. Therefore, the gross margin over that period was 74.1%.
CAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Cardinal Health, Inc. reported an operating income of 730.00M and revenue of 54.88B, resulting in an operating margin of 1.3%.
BIIB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported an operating income of 625.20M and revenue of 2.43B, resulting in an operating margin of 25.7%.
CAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Cardinal Health, Inc. reported a net income of 506.00M and revenue of 54.88B, resulting in a net margin of 0.9%.
BIIB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a net income of 240.50M and revenue of 2.43B, resulting in a net margin of 9.9%.